MedDataX Logo

Impact of Art Therapy on Alexithymia in People With Alcohol Use Disorder

NCT ID: NCT04206930

Last Updated: 2019-12-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

128 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-12-13

Study Completion Date

2022-12-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Art therapy support combined with standard care for people with an alcohol use disorder coming to a day hospital for withdrawal could be beneficial compared to standard care alone because it would improve the alexithymia of these patients, helping them to better identify their feelings and / or emotions, and improve their self-confidence, their self-esteem self and their oral communication.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Alexithymia is an inability to identify and describe one's emotions associated with outward thinking. Frequently found in people with an alcohol use disorder, a true mental handicap, alexithymia has been clearly identified as a relapse factor in addictive problems related to alcohol. The ALEXART study intends to study the evolution of alexithymia in people with an alcohol use disorder hosted in an Addictology Day Hospital unit through the use of an approach non-drug that is art therapy. Our hypothesis is that art therapy can help patients with alcohol use disorders to develop a better understanding of their own behaviors, to name their emotions and feelings, and to improve their communication with others and thereby be able to choose to change their behavior.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alexithymia Alcohol Use Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Standard support: information on alcoholic pathology, medico-psycho-social assessment, relapse prevention program

Group Type NO_INTERVENTION

No interventions assigned to this group

Art-Therapy

in addition to standard treatment, art therapy treatment program: 1 session of 2 hours per week in a closed group for 10 weeks

Group Type EXPERIMENTAL

Art Therapy

Intervention Type OTHER

1 session of 2 hours per week in a closed group for 10 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Art Therapy

1 session of 2 hours per week in a closed group for 10 weeks

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult 18 or over
* Patient with an alcohol use disorder starting day hospital care in the psychiatry and addiction department of the Angers University Hospital
* Subjects who gave and signed informed consent to participate in the study with alexithymia (Toronto Test greater than or equal to 56)

Exclusion Criteria

* Non-understanding of the French language
* Non-affiliation to a social security scheme
* Major cognitive impairment
* Motor problems preventing walking
* Protective patients
* Pregnant or lactating women
* Patients under protection of justice or deprived of liberty
* Patients under protective supervision or guardianship
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Angers

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

BENEDICTE GOHIER

Role: STUDY_DIRECTOR

CHU ANGERS SERVICE DE PSYCHIATRIE ADDICTOLOGIE

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Universitaire

Angers, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

ANAIS MOREAU

Role: CONTACT

Phone: 02.41.35.37.72

Email: [email protected]

LAURENT SAMSON

Role: CONTACT

Phone: 06.65.80.75.82

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

ANAIS MOREAU

Role: primary

LAURENT SAMSON

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017-A02031-52

Identifier Type: -

Identifier Source: org_study_id